Workout timing barely moves metabolic health, bar a small evening edge on blood sugar

Regular exercise reliably improves cardiometabolic health, but a popular question has emerged from circadian biology: does the time of day you train change how much benefit you get? Claims circulate in both directions, with some favouring fasted morning sessions and others arguing afternoon or evening exercise works better with the body's metabolic rhythms. Because advice on timing is cheap to give and easy to follow, it is worth knowing whether the evidence from controlled trials actually supports any of it. This review set out to pool every randomised trial that directly compared supervised exercise at different times of day.

The researchers searched five databases, PubMed, EMBASE, the Cochrane Library, Web of Science and Scopus, from inception to March 2026. Eligible studies were randomised controlled trials lasting at least 2 weeks that compared supervised exercise performed at different times of day in adults and reported cardiometabolic outcomes. Twelve trials with 879 participants met the criteria. The team pooled mean differences using random-effects models, ran sensitivity analyses including a leave-one-out approach, explored subgroups, and graded the certainty of the evidence for each outcome.

Later-day exercise was associated with a small reduction in fasting blood glucose of 0.16 mmol/L compared with earlier exercise, a finding that held up under a more conservative statistical adjustment and showed no disagreement between the included trials. That was the only timing effect to emerge. There were no clear differences by time of day for HbA1c, fasting insulin, HOMA-IR, blood lipids, systolic or diastolic blood pressure, BMI or fat mass. For systolic blood pressure, the trials disagreed with each other substantially, making that outcome particularly hard to read. Certainty of the evidence ranged from very low to moderate across outcomes.

This synthesis lands on the sceptical side of the exercise-timing debate: across almost every cardiometabolic marker, when you train appears to matter far less than whether you train. The small fasting glucose advantage for later sessions is consistent with the idea that timing could matter at the margins for blood sugar control, but it is a single marker and a small difference. The authors explicitly conclude that current evidence does not support a consistent advantage for any particular time of day, and call for larger, better standardised trials before timing recommendations can be made.

For most people the practical reading is reassuring: the session you can actually keep, at whatever hour, is doing the metabolic work, and there is no evidence here that a morning habit is costing you meaningful benefits. If fasting blood glucose is a number you watch, the small advantage for later-day exercise is worth knowing about, though it is modest and the evidence behind it is not yet strong. This is a reason to treat confident claims about the one best time to train with scepticism rather than a reason to reorganise your week.